David Vicente-Zurdo

Prof. Dr. David Vicente-Zurdo

Analytical Chemistry, Complutense University of Madrid, Madrid, Spain
+1
orcid
Assistant professor

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2025 in Molecules
Verified
Journal Article
Open access
PDF file
DVDavid Vicente-Zurdo
David Vicente-Zurdo
EGEsther Gomez-Mejia
Esther Gomez-Mejia
Sonia Morante-ZarceroSonia Morante-Zarcero
Sonia Morante-Zarcero
NRNoelia Rosales-Conrado
Noelia Rosales-Conrado
Isabel SierraIsabel Sierra
Isabel Sierra
Recent advancements in analytical strategies have enabled the efficient extraction and characterization of bioactive compounds from agri-food bio-residues, emphasizing green chemistry and circular economy principles. This review highlights the valorization of several agri-food bio-residues for the extraction of high-value-added bioactive compounds, particularly polyphenols, tocopherols, carotenoids, and fatty acids, as a biorefinery approach. To this end, the adoption of environmentally friendly extraction technologies is essential to improve performance, reduce energy consumption, and minimize costs. This study therefore examines emerging methodologies such as supercritical fluid extraction, pressurized liquid extraction, pulsed electric fields, and matrix solid-phase dispersion, highlighting their advantages and limitations. Additionally, the chemical characterization of these bioactive compounds is explored through spectrophotometric and high-resolution chromatographic techniques, crucial for their accurate identification and quantification. This is complemented by an analysis of bioactivity assays evaluating antioxidant, antimicrobial, anticancer, neuroprotective, and anti-inflammatory properties, with a focus on their applications in the food, pharmaceutical, and cosmetic industries. However, the analytical control of toxic compounds, such as alkaloids, in these bio-residues is undoubtedly needed. Ultimately, this approach not only promotes sustainability but also contributes to the development of eco-friendly solutions in various industries.

26 June 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
DVDavid Vicente-Zurdo
David Vicente-Zurdo
NRNoelia Rosales-Conrado
Noelia Rosales-Conrado
MGMaría Eugenia de León González
María Eugenia de León González
LBLeonardo Brunetti
Leonardo Brunetti
LPLuca Piemontese
Luca Piemontese
MSMaria Amélia Santos
Maria Amélia Santos
Alzheimer’s disease (AD) is the most serious and prevalent neurodegenerative disorder still without cure. Since its aetiology is diverse, recent research on anti-AD drugs has been focused on multi-target compounds. In this work, seven novel hybrids (RIV–BIM) conjugating the active moiety of the drug rivastigmine (RIV) with 2 isomeric hydroxyphenylbenzimidazole (BIM) units were developed and studied. While RIV assures the inhibition of cholinesterases, BIM provides further appropriate properties, such as inhibition of amyloid β-peptide (Aβ) aggregation, antioxidation and metal chelation. The evaluated biological properties of these hybrids included antioxidant activity; inhibition of acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and Aβ42 aggregation; as well as promotion of cell viability and neuroprotection. All the compounds are better inhibitors of AChE than rivastigmine (IC50 = 32.1 µM), but compounds of series 5 are better inhibitors of BChE (IC50 = 0.9−1.7 µM) than those of series 4. Series 5 also showed good capacity to inhibit self- (42.1−58.7%) and Cu(II)-induced (40.3−60.8%) Aβ aggregation and also to narrow (22.4−42.6%) amyloid fibrils, the relevant compounds being 5b and 5d. Some of these compounds can also prevent the toxicity induced in SH-SY5Y cells by Aβ42 and oxidative stress. Therefore, RIV–BIM hybrids seem to be potential drug candidates for AD with multi-target abilities.

22 April 2020 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
DVDavid Vicente-Zurdo
David Vicente-Zurdo
IRIván Romero-Sánchez
Iván Romero-Sánchez
NRNoelia Rosales-Conrado
Noelia Rosales-Conrado
MLMaría Eugenia León-González
María Eugenia León-González
Yolanda MadridYolanda Madrid
Yolanda Madrid

7 December 2023 in Talanta
Verified
Journal Article
Open access
DVDavid Vicente-Zurdo
David Vicente-Zurdo
NRNoelia Rosales-Conrado
Noelia Rosales-Conrado
MGMaría Eugenia de León González
María Eugenia de León González
Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by progressive cognitive decline and the accumulation of beta-amyloid plaques and tau tangles in the brain. Current therapies have limited efficacy, prompting the search for novel treatments. Selenium nanoparticles (SeNPs) have emerged as promising candidates for AD therapy due to their unique physicochemical properties and potential therapeutic effects. This review provides an overview of SeNPs and their potential application in AD treatment, as well as the main bioanalytical techniques applied in this field. SeNPs possess antioxidant and anti-inflammatory properties, making them potential candidates to combat the oxidative stress and neuroinflammation associated with AD. Moreover, SeNPs have shown the ability to cross the blood-brain barrier (BBB), allowing them to target brain regions affected by AD pathology. Various methods for synthesizing SeNPs are explored, including chemical, physical and biological synthesis approaches. Based on the employment of algae, yeast, fungi, and plants, green methods offer a promising and biocompatible alternative for SeNPs production. In vitro studies have demonstrated the potential of SeNPs in reducing beta-amyloid aggregation and inhibiting tau hyperphosphorylation, providing evidence of their neuroprotective effects on neuronal cells. In vivo studies using transgenic mouse models and AD-induced symptoms have shown promising results, with SeNPs treatment leading to cognitive improvements and reduced amyloid plaque burden in the hippocampus. Looking ahead, future trends in SeNPs research involve developing innovative brain delivery strategies to enhance their therapeutic potential, exploring alternative animal models to complement traditional mouse studies, and investigating multi-targeted SeNPs formulations to address multiple aspects of AD pathology. Overall, SeNPs represent a promising avenue for AD treatment, and further research in this field may pave the way for effective and much-needed therapeutic interventions for individuals affected by this debilitating disease.

15 September 2022 in LWT
Verified
Journal Article
Open access
EGEsther Gomez-Mejia
Esther Gomez-Mejia
DVDavid Vicente-Zurdo
David Vicente-Zurdo
NRNoelia Rosales-Conrado
Noelia Rosales-Conrado
MLMaría Eugenia León-González
María Eugenia León-González
YMYolanda Madrid
Yolanda Madrid

Verified
Journal Article
Open access
PDF file
DVDavid Vicente-Zurdo
David Vicente-Zurdo
EGEsther Gomez-Mejia
Esther Gomez-Mejia
NRNoelia Rosales-Conrado
Noelia Rosales-Conrado
MGMaría Eugenia de León González
María Eugenia de León González
Alzheimer’s Disease (AD), a prevalent neurodegenerative disorder, is the primary cause of dementia. Despite significant advancements in neuroscience, a definitive cure or treatment for this debilitating disease remains elusive. A notable characteristic of AD is oxidative stress, which has been identified as a potential therapeutic target. Polyphenols, secondary metabolites of plant origin, have attracted attention due to their potent antioxidant properties. Epidemiological studies suggest a correlation between the consumption of polyphenol-rich foods and the prevention of chronic diseases, including neurodegenerative disorders, which underscores the potential of polyphenols as a therapeutic strategy in AD management. Hence, this comprehensive review focuses on the diverse roles of polyphenols in AD, with a particular emphasis on neuroprotective potential. Scopus, ScienceDirect, and Google Scholar were used as leading databases for study selection, from 2018 to late March 2024. Analytical chemistry serves as a crucial tool for characterizing polyphenols, with a nuanced exploration of their extraction methods from various sources, often employing chemometric techniques for a holistic interpretation of the advances in this field. Moreover, this review examines current in vitro and in vivo research, aiming to enhance the understanding of polyphenols’ role in AD, and providing valuable insights for forthcoming approaches in this context.